ImmuneBiotech AB

ImmuneBiotech AB develops, markets, and commercializes therapeutically effective probiotic products that are designed with pharmaceutical precision to effectively manage gastrointestinal and neurological conditions.

Drawing from 20 years of groundbreaking research, ImmuneBiotech has gained a deep understanding of how the microbiome, immune system, and intestinal barrier interact to impact our health and has created a new probiotic category ImmuneBiotics™ where products are developed using pharmaceutical precision focused on achieving a healthy balance between the microbiome, the immune system, and the intestinal barrier. 

GutMagnific is an effective multi-strain probiotic food/nutritional supplement scientifically designed for management of gastrointestinal conditions but has also demonstrated clinical efficacy in neurological conditions.

GutMagnific is available to primarily Swedish and European consumers on the company’s own web-shop www.GutMagnific.com.